EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Therapeutic and Toxic Effects of Valproic Acid Metabolites

Natalia A Shnayder iD, Violetta V Grechkina, Aiperi K Khasanova iD, Elena N Bochanova, Evgenia A Dontceva, Marina M Petrova, Azat R Asadullin, German A Shipulin, Kuanysh S Altynbekov, Mustafa Al-Zamil iD, Regina F Nasyrova iD

Metabolites · 16.01.2023 · 13 (1) · 134

DOI: 10.3390/metabo13010134 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Metabolites, online erschienen am 16.01.2023. Verfasst von Natalia A Shnayder und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Personalized Psychiatry and Neurology, Shared Core Facilities, V.M. Bekhterev National Medical Research Centre for Psychiatry and Neurol…. Die Arbeit wurde bisher 87-mal zitiert (Crossref) und nennt 143 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Valproic acid (VPA) and its salts are psychotropic drugs that are widely used in neurological diseases (epilepsy, neuropathic pain, migraine, etc.) and psychiatric disorders (schizophrenia, bipolar affective disorder, addiction diseases, etc.). In addition, the indications for the appointment of valproate have been expanding in recent years in connection with the study of new mechanisms of action of therapeutic and toxic metabolites of VPA in the human body. Thus, VPA is considered a component of disease-modifying therapy for multiple tumors, neurodegenerative diseases (Huntington’s disease, Parkinson’s disease, Duchenne progressive dystrophy, etc.), and human immunodeficiency syndrome. The metabolism of VPA is complex and continues to be studied. Known pathways of VPA metabolism include: β-oxidation in the tricarboxylic acid cycle (acetylation); oxidation with the participation of cytochrome P-450 isoenzymes (P-oxidation); and glucuronidation. The complex metabolism of VPA explains the diversity of its active and inactive metabolites, which have therapeutic, neutral, or toxic effects. It is known that some active metabolites of VPA may have a stronger clinical effect than VPA itself. These reasons explain the relevance of this narrative review, which summarizes the results of studies of blood (serum, plasma) and urinary metabolites of VPA from the standpoint of the pharmacogenomics and pharmacometabolomics. In addition, a new personalized approach to assessing the cumulative risk of developing VPA-induced adverse reactions is presented and ways for their correction are proposed depending on the patient’s pharmacogenetic profile and the level of therapeutic and toxic VPA metabolites in the human body fluids (blood, urine).

Schlagwörter

Stichwörter der Autor:innen

acetylationadverse drug reactionblood metaboliteglucuronidationoxidationpersonalized approachpharmacogenomicspharmacometabolomicsrisk factorurinal metabolitevalproic acid

Autor:innen und Institutionen

  • Institute of Personalized Psychiatry and Neurology, Shared Core Facilities, V.M. Bekhterev National Medical Research Centre for Psychiatry and Neurology, 192019 Saint Petersburg, Russia.
  • Shared Core Facilities "Molecular and Cell Technologies", V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, 660022 Krasnoyarsk, Russia.
  • Department of Psychiatry, Russian Medical Academy for Continual Professional Education, 125993 Moscow, Russia.
  • Department of Psychiatry and Addiction, Bashkir State Medical University, 45000 Ufa, Russia.
  • Centre for Strategic Planning and Management of Biomedical Health Risks, 119121 Moscow, Russia.
  • Republican Scientific and Practical Center of Mental Health, Almaty 050022, Kazakhstan.

ORCID-Profile: Natalia A Shnayder, Aiperi K Khasanova, Mustafa Al-Zamil, Regina F Nasyrova

Zitieren

APA

Shnayder, N. A., Grechkina, V. V., Khasanova, A. K., Bochanova, E. N., Dontceva, E. A., Petrova, M. M., Asadullin, A. R., Shipulin, G. A., Altynbekov, K. S., Al-Zamil, M., & Nasyrova, R. F. (2023). Therapeutic and Toxic Effects of Valproic Acid Metabolites. Metabolites, 13(1), 134. https://doi.org/10.3390/metabo13010134

Vancouver

Shnayder NA, Grechkina VV, Khasanova AK, Bochanova EN, Dontceva EA, Petrova MM, et al. Therapeutic and Toxic Effects of Valproic Acid Metabolites. Metabolites. 2023;13(1):134. doi:10.3390/metabo13010134

BibTeX
@article{Shnayder2023,
  author = {Shnayder, Natalia A and Grechkina, Violetta V and Khasanova, Aiperi K and Bochanova, Elena N and Dontceva, Evgenia A and Petrova, Marina M and Asadullin, Azat R and Shipulin, German A and Altynbekov, Kuanysh S and Al-Zamil, Mustafa and Nasyrova, Regina F},
  title = {Therapeutic and Toxic Effects of Valproic Acid Metabolites},
  journal = {Metabolites},
  year = {2023},
  volume = {13},
  number = {1},
  pages = {134},
  doi = {10.3390/metabo13010134}
}
Kostenlos starten →